Prediction of treatment outcome in cocaine dependent males using quantitative EEG.
This study investigates the existence of outcome related neurophysiological subtypes within a population of abstinent cocaine dependent adults. We have previously reported and replicated the existence of a distinctive quantitative EEG (QEEG) profile in such a population, and demonstrated the persistence of this pattern at one and six month follow-up evaluations. This profile is characterized by significant deficits of absolute and relative delta and theta power, and excess of relative alpha power, as compared with age expected normal values. Abnormalities were greater in anterior than posterior regions, and disturbances in interhemispheric relationships were also observed. In the current study, 35 adult males with DSM-III-R cocaine dependence, were evaluated while residents of a drug-free residential therapeutic community, 5-15 days after last use of crack cocaine. Using multivariate cluster analysis, two neurophysiological subtypes were identified from the baseline QEEGs; Cluster 1 characterized by significant deficits of delta and theta activity, significant excess of alpha activity and more normal amounts of beta activity (alpha CLUS) and Cluster 2 characterized by deficits of delta, more normal amounts of theta and anterior excess of alpha and beta activity beta CLUS). No significant relationships were found between QEEG subtype membership and length of exposure to cocaine, time since last use of cocaine or any demographic characteristics. Further, no significant relationships were found between the commonly reported comorbid clinical features of depression and anxiety and subtype membership. However, a significant relationship was found between QEEG subtype membership and length of stay in treatment, with members of the alpha CLUS retained in treatment significantly longer than members of the beta CLUS.
Prichep
L S
LS
Department of Psychiatry, New York University School of Medicine, NY 10016, USA.
Alper
K R
KR
Kowalik
S C
SC
Vaysblat
L S
LS
Merkin
H A
HA
Tom
M
M
John
E R
ER
Rosenthal
M S
MS
D000293:Adolescent; D000328:Adult; D001931:Brain Mapping; D019970:Cocaine-Related Disorders / Q000150:complications / Q000534:rehabilitation*; D003866:Depressive Disorder / Q000150:complications / Q000175:diagnosis; D004569:Electroencephalography / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011314:Preventive Health Services; D011379:Prognosis; D011446:Prospective Studies; D011569:Psychiatric Status Rating Scales; D012114:Residential Treatment; D016896:Treatment Outcome